home.social

#bridgebio — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #bridgebio, aggregated by home.social.

  1. Yonhap Infomax News @[email protected] ·

    South Korean pharmaceutical company Yuhan Corp. secures 56 billion won supply contract with US biotech firm BridgeBio to provide active pharmaceutical ingredients for cardiomyopathy treatment through March 2028, marking significant expansion in global pharmaceutical supply chain partnerships.
    #YonhapInfomax #YuhanCorp #BridgeBio #CardiomyopathyTreatment #ApiSupply #PharmaceuticalContract #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #yuhancorp #bridgebio #cardiomyopathytreatment #apisupply #pharmaceuticalcontract
  2. Yonhap Infomax News @[email protected] ·

    South Korean pharmaceutical company Yuhan Corp. secures 56 billion won supply contract with US biotech firm BridgeBio to provide active pharmaceutical ingredients for cardiomyopathy treatment through March 2028, marking significant expansion in global pharmaceutical supply chain partnerships.
    #YonhapInfomax #YuhanCorp #BridgeBio #CardiomyopathyTreatment #ApiSupply #PharmaceuticalContract #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #yuhancorp #bridgebio #cardiomyopathytreatment #apisupply #pharmaceuticalcontract
  3. Yonhap Infomax News @[email protected] ·

    South Korean pharmaceutical company Yuhan Corp. secures 56 billion won supply contract with US biotech firm BridgeBio to provide active pharmaceutical ingredients for cardiomyopathy treatment through March 2028, marking significant expansion in global pharmaceutical supply chain partnerships.
    #YonhapInfomax #YuhanCorp #BridgeBio #CardiomyopathyTreatment #ApiSupply #PharmaceuticalContract #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  4. Yonhap Infomax News @[email protected] ·

    South Korean pharmaceutical company Yuhan Corp. secures 56 billion won supply contract with US biotech firm BridgeBio to provide active pharmaceutical ingredients for cardiomyopathy treatment through March 2028, marking significant expansion in global pharmaceutical supply chain partnerships.
    #YonhapInfomax #YuhanCorp #BridgeBio #CardiomyopathyTreatment #ApiSupply #PharmaceuticalContract #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #yuhancorp #bridgebio #cardiomyopathytreatment #apisupply #pharmaceuticalcontract